Guggenheim Capital’s NEVRO CORP. NVRO Stock Holding History

Guggenheim Capital’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,096	Closed	-$224K	–	2155
2022 Q1	$224K	Sell	3,096 -435	-12%	-$31.4K	﹤0.01%	2004
2021 Q4	$286K	Buy	+3,531	New	+$354K	﹤0.01%	1893
2021 Q1	–	Sell	-1,220	Closed	-$211K	–	2180
2020 Q4	$211K	Buy	+1,220	New	+$198K	﹤0.01%	1937
2017 Q4	–	Sell	-4,838	Closed	-$439K	–	2828
2017 Q3	$439K	Sell	4,838 -177	-4%	-$15.2K	﹤0.01%	2437
2017 Q2	$373K	Buy	5,015 +1,984	+65%	+$159K	﹤0.01%	2496
2017 Q1	$284K	Sell	3,031 -301	-9%	-$27.3K	﹤0.01%	2564
2016 Q4	$242K	Sell	3,332 -34	-1%	-$2.91K	﹤0.01%	2656
2016 Q3	$351K	Buy	+3,366	New	+$304K	﹤0.01%	2511

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Guggenheim Capital's NVRO Position: Q2 2022 in Review

Guggenheim Capital sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 3,096 shares — an estimated $224K sold.

Guggenheim Capital first reported a position in NVRO in Q3 2016 and held it in 8 quarters. The position peaked at $439K in Q3 2017. 175 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

Guggenheim Capital reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
Guggenheim Capital sold 3,096 NEVRO CORP. shares in Q2 2022, an estimated $224K.
Guggenheim Capital first reported a position in NEVRO CORP. in Q3 2016 and held it in 8 quarters.
Guggenheim Capital's NEVRO CORP. position peaked at $439K in Q3 2017.
175 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.